PlasmaTech, Inc. PMAH

Company Overview

PlasmaTech, Inc. (OTC: PMAH) is a publicly traded company that has historically been associated with the biotechnology and specialty pharmaceutical sector, with a particular focus on plasma-derived therapeutics and healthcare-related acquisitions. Public disclosures and historical market records indicate that the company previously operated under variations of the PlasmaTech name and pursued strategies centered on acquiring or developing healthcare and biopharmaceutical assets. Available information from historical filings, OTC market disclosures, and financial databases suggests the company’s activities were tied to specialty biologics, plasma-based therapies, and related intellectual property initiatives.

The company’s historical business model appears to have relied primarily on acquisitions, licensing arrangements, and the development or commercialization of healthcare-related products rather than large-scale manufacturing operations. Publicly available records indicate that the company underwent multiple strategic and corporate restructurings over time. However, current operational details, active revenue-generating business lines, and updated financial disclosures are limited. Data inconclusive based on available public sources regarding the company’s present operating scale, commercial activity, and long-term strategic positioning.